Assertion: In gene therapy of SCID, a pa...

Assertion: In gene therapy of SCID, a patient requires periodic infusion of genetically engineered lymphocytes
Reason :If the ADA gene is introducted into cells at early embryonic stage, it could be a permanent cure

Similar Questions

Explore conceptually related problems

Why is the introduction of genetically engineered lymphocytes in to ADA deficiency patient is not a permanent cure? Suggest a possible permanent cure

Why are repeated transfusions of genetically engineered cells required in SCID patients ?

Why is repated transfusions of genetically engineered cells required in SCID patients?

Why is the introduction of genetically engineered lymphocytes into ADA deficiency patient not a permanent cure? Suggest a possible permanent cure.

Why is the introduction of genetically engineered lymphocytes into a ADA deficiency patient not a permanent cure? Suggest a possible permanent cure.

Why is the introduction of genetically engineered lymphocytes into an ADA deficieny patient not a permanent cure ? Suggest a possible permanent cure.

Why is the introduction of genetically engineered lymphocytes into a ADA deficiency patient not a permanent cure ? Suggest a possible permanent cure.